Just-Evotec Takes J.Train Continuous Platform to Market

Just-Evotec has launched its J.Train continuous biomanufacturing platform to the broader market following validation through a facility sale to Sandoz. The platform integrates end-to-end continuous processing using single-use perfusion bioreactors, enabling higher productivity and reduced manufacturing footprint compared to traditional batch methods.